One in four Australians are diagnosed with cancer during their lives. Even when correctly diagnosed, the best cancer treatments achieve only a 48 percent success rate over three years.1

A key to better predicting patient treatment outcomes for cancer sufferers lies in finding and interpreting the patterns and genes of significance in the genomes of patients who have responded best to previous treatments.

This World Cancer Day, we’re proud to share the inspiring work that Brisbane-based machine learning consultancy, Max Kelsen, is doing with artificial intelligence (AI) to better predict patient responses to cancer treatments such as immunotherapy.

Their Immunotherapy Outcome Prediction (IOP) has the potential to change the lives of millions of cancer patients worldwide. Working alongside genomiQa, QIMR Berghofer, BGI, and QLD Health Metro North Hospital and Health Service, Max Kelsen plans to integrate AI and whole genome sequencing into cancer research and clinical practice and putting us one step closer to fully personalized, highly effective treatment plans.